Standardize the market order blood products industry to a new starting point
Blood products industry consolidation over the past three years of treatment, the path of the future healthy development of the road, single plasma collection stations will be restructuring the original separate upstream and downstream industry chain, opened up a far-reaching significance. We expect to vote in the next three years the industry will slow recovery of the plasma volume, the industry is still in short supply situation, prices remain high.
Blood products industry oligopoly structure will gradually master the three advantages of leading enterprises will likely emerge as the leading national or regional companies.
Pulp station opened up on the downstream industry chain conversion
2006 4 11, the State Development and Reform Commission, Ministry of Health, Food and Drug Administration (SFDA) and other nine ministries jointly issued a "transformation of the work program on the plasma stations", the Plan has the health sector and plasma collection stations decoupling, county health administration department no longer set the plasma collection stations were originally under the county-level health administrative departments to set the plasma stations convert the grounds set manufacturers of blood products. Manufacturers of blood products in the investment ratio not less than 80%.
After conversion, plasma collection stations will serve as the raw material for manufacturers of blood products workshop, blood products company ownership and management rights and open up the upstream and downstream industry chain, and blood products companies through the direct management of plasma collection stations , through various means to protect the pulp quality and safety of the source, before the chaos caused by the industry's three major issues will be resolved.
First, the blood products companies through the grasp of the market demand, control plasma collection capacity in order to avoid imbalance between supply and demand situation is conducive to rational use of resources in plasma, blood products also help enterprises to adopt plasma volume and plasma quality control.
Second, plasma donation treatment have increased the possibility. In the blood products business through the acquisition of plasma collection stations, the middle part of the costs will decline, we believe that the strength of the leading enterprises have increased plasma donation by staff members of the treatment to the development of plasma donation plasma donation and the establishment of a stable staff team; third, the state, the plasma stations after the conversion, control and operation of separation more favorable regulation; same time, with increasingly stringent regulation, the safety of blood products to further improve.
The next three years a high degree of economy
Industry since 2004 experienced a four-year restructuring period of consolidation, during which plasma collection volume decreases, the product prices. Finally the end of 2008, the industry's turmoil, all the slurry station transfer is completed. The new standard pulp station has also been introduced, so we judge to vote in 2008 will be the pulp industry is gradually restored in the first year.
Plasma collection volume recovery will slow. We determine the country's mining plasma volume recovery in 2008-2010, slowly. Restructuring since the single plasma collection station has just ended, in 2008 and quarantine measures such as the implementation of the national situation for pulp unlikely return to the chaos before 2003, so can not vote in plasma volume in the short term rapid recovery.
Second, product prices continue to remain high. Slow recovery in the context of plasma, the product supply and demand is still uneven, so we judge human serum albumin in 2008-2010 prices will remain high stability. Meanwhile, members of the treatment increased plasma donation and tons of pulp collection, testing cost increase is inevitable and will bring the cost of plasma enhanced and this is the price of blood products to maintain one of the factors.
Oligopolistic industry grow into the early
Leading enterprises from the top of the industry chain?? Plasma collection stations in the quantity, quality, management began to downstream product development, production and sales are already formed a strong competitive advantage, we believe that our blood products oligopolistic industry, the pattern has taken shape, the future market of China's blood products will form a national leading enterprises at home 1-2, 5-6 regional leading enterprises, these small, single product, the enterprise market will be weak phased out.
We believe that the plasma source management, product and technology, and marketing the industry leading standard form.
I am China Quality Dress writer, reports some information about rigid heddle looms , blue tempered spring steel.
Processing your request, Please wait....
